Product Images Everolimus
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Everolimus NDC 0093-7768 by Teva Pharmaceuticals Usa, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
1 - images 1
2 - images 2
1 - images 3
This is a summary of statistical analysis of a study related to cancer treatment with a drug called Everolimus compared with a placebo. The Hazard Ratio and Logrank p value are provided with the probability percentage. Additionally, Kaplan-Meier medians are reported for both treatment groups. It also mentions the censoring times for both the groups at week 4.*
1 - images 4
This appears to be a graph or table showing the probability of an event occurring over time for two different treatments, Everolimus + BSC and Placebo + BSC. The table also shows the number of patients at risk at each time point. The exact event being measured and the context of the data are not clear.*
1 - images 5
This appears to be a statistical output from a study or experiment involving two groups (Everolimus and Placebo). The table shows probability percentages and censoring times, as well as a hazard ratio and confidence interval with a significant p-value. Additionally, there are Kaplan-Meier medians for the two groups, indicating a significant difference in survival time between the two groups.*
2.5mg - images 6
5mg - images 7
7.5 mg - images 8
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.